Addison Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Addison Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.2K	Sell	115 -420	-79%	-$56.8K	0.01%	349
2026 Q1	$68.3K	Hold	535	–	–	0.02%	373
2025 Q4	$65.2K	Hold	535	–	–	0.01%	375
2025 Q3	$53.6K	Hold	535	–	–	0.01%	409
2025 Q2	$44.4K	Hold	535	–	–	0.01%	423
2025 Q1	$43.4K	Hold	535	–	–	0.01%	402
2024 Q4	$48.2K	Buy	535 +115	+27%	+$11.1K	0.01%	394
2024 Q3	$41.5K	Hold	420	–	–	0.01%	417
2024 Q2	$38.9K	Sell	420 -150	-26%	-$13.4K	0.01%	408
2024 Q1	$54.1K	Hold	570	–	–	0.02%	354
2023 Q4	$50.9K	Sell	570 -23	-4%	-$1.71K	0.02%	355
2023 Q3	$43.3K	Hold	593	–	–	0.02%	346
2023 Q2	$49.3K	Sell	593 -200	-25%	-$16.7K	0.02%	317
2023 Q1	$60.4K	Sell	793 -125	-14%	-$10.4K	0.03%	280
2022 Q4	$76.2K	Sell	918 -189	-17%	-$15.3K	0.05%	247
2022 Q3	$88K	Buy	1,107 +60	+6%	+$5.06K	0.05%	203
2022 Q2	$78K	Sell	1,047 -295	-22%	-$22.1K	0.05%	217
2022 Q1	$121K	Buy	1,342 +200	+18%	+$18.5K	0.07%	195
2021 Q4	$128K	Buy	1,142 +722	+172%	+$87.1K	0.08%	161
2021 Q3	$53K	Hold	420	–	–	0.04%	178
2021 Q2	$57K	Buy	+420	New	+$55.2K	0.05%	173
2020 Q4	$39K	Buy	+280	New	+$35.9K	0.04%	198

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Addison Advisors's XBI Position: Q2 2026 in Review

Addison Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 79% in Q2 2026, selling an estimated $56.8K and leaving 115 shares worth $18.2K. The position accounts for 0.01% of the portfolio, ranked #349.

Addison Advisors first reported a position in XBI in Q4 2020 and has held it in 22 quarters since. The position peaked at $128K in Q4 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Addison Advisors held 115 shares of State Street SPDR S&P Biotech ETF worth $18.2K as of Q2 2026.
Addison Advisors sold 420 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $56.8K.
State Street SPDR S&P Biotech ETF made up 0.01% of Addison Advisors's portfolio in Q2 2026, its #349 holding.
Addison Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 22 quarters since.
Addison Advisors's State Street SPDR S&P Biotech ETF position peaked at $128K in Q4 2021.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.